Hints and tips:
Related Special Reports
...In October 2019, Merck also completed a €5.8bn acquisition of US-based Versum Materials, which makes critical components used in semiconductors. Merck declined to comment....
...BCG is working with global tech giants and AI companies — from Microsoft and Google to OpenAI and Anthropic — to integrate their technology into company operations and processes....
...Merck, which employs 64,000 people, is the world’s oldest pharmaceutical company, tracing its history back to 1668. The founding family still owns 70 per cent of the company....
...“We are very disappointed with the results,” said Merck’s global head of research and development and its healthcare business chief medical officer Danny Bar-Zohar, adding that the company would continue...
...Merck KGaA chief Belén Garijo will be all too aware of the highs and sudden crushing lows of drug trials....
...Merck Mercuriadis, adviser to Hipgnosis Songs Fund, has offered to drop a controversial clause giving him the right to buy the group’s music portfolio as he battles to stay on at the investment trust he...
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Shares in Daiichi Sankyo jumped as much as 18 per cent after it agreed on a deal worth up to $22bn with Merck to develop and commercialise three of the Japanese pharmaceutical company’s drug candidates to...
...Hipgnosis was founded by music executive Merck Mercuriadis in 2018 to turn music rights into a mainstream asset class, using the rising royalties from streaming, radio play and performances to provide income...
...HSF was founded by music executive Merck Mercuriadis in 2018 to turn music rights into an asset class. He was HSM’s chief executive until February, when he became its chair....
...As they garner more information about their companies — assuming it is positive — they hold fast. Of course it cuts both ways....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...The Swiss company already has a packed pipeline. The problem is that too many drug trials have failed. Merck knows how that feels....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...The company reported a loss of $2.06 a share, which was mainly due to a charge related to an acquisition....
...odds are greatly improved for late entrants when they are second entrants to the market, fast followers (launched within the same year or one year after the first entrant), and marketed by a large pharma company...
...But the company was ultimately unable to get permission to operate locally....
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...The companies said Moderna’s mRNA cancer vaccine, when used in concert with Merck’s blockbuster cancer drug Keytruda, helped cut the chance of late-stage skin cancer from returning after three years by 49...
...The CIA’s Patel says more companies are waking up to the dangers. “Since the Russia-Ukraine conflict, the private sector has been much more forward-leaning,” she notes....
...Months earlier Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company, according to two people with knowledge of its content....
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...Big share price moves in Europe on Wednesday include German tour operator Tui, German pharmaceutical company Merck, and London-listed British American Tobacco: Tui: Shares in the tour operator surged 6.3...
...Merck Mercuriadis, who established Hipgnosis in 2018 and is now chief executive of the fund’s investment adviser — Hipgnosis Song Management — said the AGM “marks an opportunity to reset and focus on the...
International Edition